Quedas na doença de Huntington

• Ano de defesa: 2022
• Autor(a) principal: Arthur Pena Ferreira
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Minas Gerais; Brasil; Programa de Pós-Graduação em Ciências Aplicadas à Saúde do Adulto; UFMG
• Palavras-chave em Português: Doença de Huntington; Quedas; Distúrbios de marcha; Distúrbios do equilíbrio; Neurolépticos; Instabilidade postural; Acidentes por Quedas; Equilíbrio Postural; Antipsicóticos; Coreia; Transtornos Neurológicos da Marcha.; Dissertação Acadêmica
• Link de acesso: http://hdl.handle.net/1843/46626

Introduction: Falls are associated with injuries, fear of falling, decreased functional mobility and worsening in quality of life. However, little is known about the potentially contributing factors to the occurrence of falls in Huntington's Disease (HD) as well as the circumstances in which they occur. Objectives: To investigate clinical features potentially associated with an increased risk of falls in HD, as well as the circumstances in which falls occur and their consequences.Methods: Demographic and clinical data was obtained through interviews, chart review and physical examination. Instruments for fall risk assessment (TUG), motor symptoms (UHDRS, UPDRS), gait disorders (10MWT, FOG), cognitive disorders (MMSE, FAB, FDT, Hayling, Ekman), behavioral changes (Irritability Scale, BIS- 11, BDI-II, NPI-Q) and balance disorders (BBS) were applied to all patients.Results: Data from 40 patients was obtained and 24 (60%) had ≥ 2 falls in the last 6 months and were considered “recurrent fallers”. Age, age of disease onset and disease duration (DCL) did not differ between groups. In contrast, the dose of neuroleptics measured in olanzapine equivalents (EO) was higher in the “recurrent fallers” group. The “recurrent fallers” also showed worse performance in the execution of the UHDRS-TMS, UPDRS, BBS and more chorea than the “non-fallers”. There was also a statistical difference in the comparison of times of choice and alternation of the FDT, indicating worse cognitive performance of the “recurrent fallers” group in the test. “Recurrent fallers” also showed more aberrant motor behavior than “non-fallers”. There was no difference in the comparison of the spatio-temporal gait parameters studied, nor in the TUG performance. Both groups had high rates of fear of falling. Only the model containing the BBS reached statistical significance in the logistic regression. About 80% of falls occurred indoors, walking was the most common act during falls. In addition, 40% of falls were classified as intrinsic. Conclusion: Falls are frequent in HD as well as the fear of falling. Our study suggests that the risk of falls in Huntington's disease is multifactorial. High doses of neuroleptics, chorea, cognitive and behavioral symptoms and particularly balance disorders contribute to the occurrence of falls in HD.